Пятый элемент здоровья. Как использовать менструальный цикл для поддержания жизненно важных функций организма

40. Nair, Rathish, and Arun Maseeh. “Vitamin D: the ‘sunshine’ vitamin.” Journal of Pharmacology & Pharmacotherapeutics 3, no. 2 (2012): 1–18; Libon, Florence, Justine Courtois, Caroline Le Goff, Pierre Lukas, Neus Fabregat-Cabello, Laurence Seidel, Etienne Cavalier, and Arjen F. Nikkels. “Sunscreens block cutaneous vitamin D production with only a minimal effect on circulating 25-hydroxyvitamin D.” Archives of Osteoporosis 12, no. 1 (2017): 66; Matsuoka, L.Y., L. Ide, J. Wortsman, J.A. MacLaughlin, and M.F. Holick. “Sunscreens suppress cutaneous vitamin D₃ synthesis.” The Journal of Clinical Endocrinology and Metabolism 64, no. 6 (1987): 1165–1168; Sambandan, Divya R., and Desiree Ratner. “Sunscreens: an overview and update.” Journal of the American Academy of Dermatology 64, no. 4 (2011): 748–758; Kullavanijaya, Prisana, and Henry W. Lim. “Photoprotection.” Journal of the American Academy of Dermatology 52, no. 6 (2005): 937–958; Faurschou, A., D.M. Beyer, Anne Schmedes, M.K. Bogh, P.A. Philipsen, and H.C. Wulf. “The relation between sunscreen layer thickness and vitamin D production after ultraviolet B exposure: a randomized clinical trial.” British Journal of Dermatology 167, no. 2 (2012): 391–395; Norval, M., and Hans Chr Wulf. “Does chronic sunscreen use reduce vitamin D production to insufficient levels?” British Journal of Dermatology 161, no. 4 (2009): 732–736.

41. Schmid, Alexandra, and Barbara Walther. “Natural vitamin D content in animal products.” Advances in Nutrition: An International Review Journal 4, no. 4 (2013): 453–462.

42. McKenna, M.J., and R. Freaney. “Secondary hyperparathyroidism in the elderly: means to defining hypovitaminosis D.” Osteoporosis International 8, no. 8 (1998): S003–S006; Gómez-Alonso, Carlos, Manuel L. Naves-Díaz, Jose L. Fernández– Martín, Jose B. Díaz-López, Maria T. Fernández-Coto, and Jorge B. Cannata-Andía. “Vitamin D status and secondary hyperparathyroidism: the importance of 25-hydroxyvitamin D cut-off levels.” Kidney International 63 (2003): S44–S48; Holick, Michael F. “Vitamin D deficiency.” New England Journal of Medicine 357, no. 3 (2007): 266–281; Souberbielle, Jean– Claude, Jean-Jacques Body, Joan M. Lappe, Mario Plebani, Yehuda Shoenfeld, Thomas J. Wang, Heike A. Bischoff-Ferrari et al. “Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice.” Autoimmunity Reviews 9, no. 11 (2010): 709–715; Vieth, Reinhold. “Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults.” The Journal of Steroid Biochemistry and Molecular Biology 89 (2004): 575–579.

43. Daniele, C., J. Thompson Coon, M.H. Pittler, and E. Ernst. “Vitex agnus castus: a systematic review of adverse events, 2005.” Drug Safety 28, no. 4: 319–332.

44. Там же; Milewicz, A., E. Gejdel, H. Sworen, K. Sienkiewicz, J. Jedrzejak, T. Teucher, and H. Schmitz. “Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinaemia. 1. Results of a randomized placebo– controlled double blind study.” Arzneimittel Forschung 43 (1993): G-752.

45. Jang, Su Hee, Dong Il Kim, and Min-Sun Choi. “Effects and treatment methods of acupuncture and herbal medicine for premenstrual syndrome/premenstrual dysphoric disorder: systematic review.” BMC Complementary and Alternative Medicine 14, no. 1 (2014): 1–13; Cerqueira, Raphael O., Benicio N. Frey, Emilie Leclerc, and Elisa Brietzke. “Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review.” Archives of Women’s Mental Health 20, no. 6 (2017): 713–719; van Die, M. Diana, Henry G. Burger, Helena J. Teede, and Kerry M. Bone. “Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials.” Planta Medica 79, no. 07 (2013): 562–575; Dante, Giulia, and Fabio Facchinetti. “Herbal treatments for alleviating premenstrual symptoms: a systematic review.” Journal of Psychosomatic Obstetrics & Gynecology 32, no. 1 (2011): 42–51; Schellenberg, Rftsg. “Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study.” The BMJ 322, no. 7279 (2001): 134–137.

Глава 16